Profile
Dennis J.
Church is currently the Director of Research & Alliance at Xigen SA. Prior to this, he worked as a Principal at Glaxo-Welcome's Research Institute.
Dennis J. Church active positions
| Companies | Position | Start |
|---|---|---|
Xigen SA
 Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Corporate Officer/Principal | 16/11/2009 |
Former positions of Dennis J. Church
| Companies | Position | End |
|---|---|---|
| Glaxo-Welcomes' Research Institute | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Xigen SA
Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Health Technology |
| Glaxo-Welcomes' Research Institute |
- Stock Market
- Insiders
- Dennis J. Church
